Mario Fsadni

Position: Therapeutic Area Head Ophthalmology at Annexin since 2022

Education and professional experience: Mario Fsadni, MBChB, MRCOphth, MSc, LLM, FMH, obtained his Medical Degree and Ophthalmology training in Manchester, UK. He brings experience gained over several years of ophthalmic drug development. He was previously the Global Medical Director at Novartis Ophthalmics and Director Product Development (Ophthalmology) at Allergan, before starting a consultancy designed specifically for the development of pharmaceutical products for ophthalmic disorders. Mario has had an active part in projects spanning all sub-therapeutic areas in ophthalmology, sixteen of which have had successful global marketing approval.

Shareholdings in the Company: No shares. 200 000 share option rights serie 2022/2025.